Unknown

Dataset Information

0

Labeling and Characterization of Human GLP-1-Secreting L-cells in Primary Ileal Organoid Culture.


ABSTRACT: Glucagon-like peptide-1 (GLP-1) from intestinal L-cells stimulates insulin secretion and reduces appetite after food ingestion, and it is the basis for drugs against type-2 diabetes and obesity. Drugs targeting L- and other enteroendocrine cells are under development, with the aim to mimic endocrine effects of gastric bypass surgery, but they are difficult to develop without human L-cell models. Human ileal organoids, engineered by CRISPR-Cas9, express the fluorescent protein Venus in the proglucagon locus, enabling maintenance of live, identifiable human L-cells in culture. Fluorescence-activated cell sorting (FACS)-purified organoid-derived L-cells, analyzed by RNA sequencing (RNA-seq), express hormones, receptors, and ion channels, largely typical of their murine counterparts. L-cells are electrically active and exhibit membrane depolarization and calcium elevations in response to G-protein-coupled receptor ligands. Organoids secrete hormones in response to glucose and other stimuli. The ability to label and maintain human L-cells in organoid culture opens avenues to explore L-cell function and develop drugs targeting the human enteroendocrine system.

SUBMITTER: Goldspink DA 

PROVIDER: S-EPMC7342002 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Labeling and Characterization of Human GLP-1-Secreting L-cells in Primary Ileal Organoid Culture.

Goldspink Deborah A DA   Lu Van B VB   Miedzybrodzka Emily L EL   Smith Christopher A CA   Foreman Rachel E RE   Billing Lawrence J LJ   Kay Richard G RG   Reimann Frank F   Gribble Fiona M FM  

Cell reports 20200601 13


Glucagon-like peptide-1 (GLP-1) from intestinal L-cells stimulates insulin secretion and reduces appetite after food ingestion, and it is the basis for drugs against type-2 diabetes and obesity. Drugs targeting L- and other enteroendocrine cells are under development, with the aim to mimic endocrine effects of gastric bypass surgery, but they are difficult to develop without human L-cell models. Human ileal organoids, engineered by CRISPR-Cas9, express the fluorescent protein Venus in the proglu  ...[more]

Similar Datasets

| S-EPMC8476785 | biostudies-literature
| S-EPMC3684363 | biostudies-literature
2020-03-31 | GSE138554 | GEO
| S-EPMC3060028 | biostudies-literature
| PRJNA576369 | ENA
| S-EPMC4087144 | biostudies-literature
| S-EPMC3380284 | biostudies-literature
| S-EPMC7611838 | biostudies-literature
| S-EPMC5835153 | biostudies-literature
| S-EPMC6627543 | biostudies-literature